Gastrointestinal Drugs Market

1
Gastrointestinal Drugs Market Global Industry
Analysis, Trends, Market Size Forecasts to 2023
2
Infinium Global Research has added a new
report on Global Gastrointestinal Drugs
Market. The report predicts the market size
of Gastrointestinal Drugs is expected to reach
XX billion by 2023. The report on global
Gastrointestinal Drugs Market provides
qualitative and quantitative analysis for
the period of 2017 to 2023. According to the
report the global Gastrointestinal Drugs Market
value is projected to reach USD 59.83 billion by
2023, growing with a CAGR of 4.5 to 5.0 from
2017 to 2023. The global Gastrointestinal Drugs
Market size was totaled 46.5 Billion in
2016. Get a Sample Report _at_ https//www.infiniumg
lobalresearch.com/Reports/MakeSampleRequest/768 M
arket Insights Global gastrointestinal drugs
market experienced progressive growth over
the past few years. As per the report
published by world gastrointestinal
organization in 2015, almost 35-40 of
worlds population is suffering from acute
and chronic gastrointestinal complications.
This includes gastrointestinal disease
and disorder, due to change and
dietary pattern, which is predominantly
responsible for global growth of this
market. Moreover, rising prevalence of
gastrointestinal disease across the globe is
equally drives global growth. Increasing
investment in research and development
activities in older to develop new drugs
along with growing awareness pertaining to
availability of these treatments have raised
considerable demand for GI drugs. Apart
from this, technological reforms in the
treatment offers superior outputs and
expected to contribute significantly in the
forthcoming years. The exact cause of GI
related disorders are still unknown, due to
which cure for these disorders is not
available. This may hamper global growth of
gastrointestinal drugs market by inviting various
complications.
Segments Covered The report segments the
global Gastrointestinal Drugs market by drug
category, by route of administration, by
disease type, by end user and by region. The
market size of each segment has been provided in
terms of value (USD). Market segmentation based
on type of drugs category includes Acid
Neutralizers, Antidiarrheal and Laxatives,
antiemetic, Anti-inflammatory, and others.
Wherein acid neutralizers further sub
segmented into antacids, H2 antagonists, and
Proton Pump Inhibitor. On the basis of
route of administration global market has
been segmented into oral, parenteral, and
rectal. Moreover, Market based on disease
type includes gastro- esophageal reflux
disorder (GERD), Inflammatory bowel
disease, and other, whereas, end user
segment comprises hospital pharmacies, retail
pharmacies and other.
3
Make an Enquiry _at_ https//www.infiniumglobalresear
ch.com/Reports/MakeEnquiryRequest/768 Company
Profiles Abbott Laboratories Allergan Plc
AstraZeneca Bayer AG Boehringer Ingelheim GmbH
GlaxoSmithKline Plc. Janssen Biotech Inc.
Sanofi Takeda Pharmaceutical Valeant
Pharmaceuticals Inc.
4

• Key topics covered
• Preface
• Executive Summary
• Global Gastrointestinal Drugs Market Overview
• Global Gastrointestinal Drugs Market IGR
  Snapshots
• Global Gastrointestinal Drugs by Drug Category
  (USD Billion) 2017 2023
• Global Gastrointestinal Drugs Market Analysis, by
  Route Of Administration (USD Billion) 2017
  2023
• Global Gastrointestinal Drugs Market Analysis, by
  Disease Type (USD Billion) 2017 2023
• Global Gastrointestinal Drugs Market Analysis, by
  End User (USD Billion) 2017 2023
• Global Gastrointestinal Drugs Market Analysis, by
  Region (USD Billion) 2017 2023
• Company Profiles
• Click to View Complete Report _at_
  https//www.infiniumglobalresearch.com/healthcare_
  medical_devices/global_gastrointestinal_drugs_
  market